Health18 hours ago
FDA Grants Breakthrough Designation to Incyte’s Blood Cancer Drug
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Incyte’s experimental drug, INCA033989, aimed at treating a rare blood cancer known as...